Company intelligence / Profile preview

Bracco Sine Pharmaceutical

Shanghai, Shanghai, China

Ownership: Private
Employees: ~600
Development stage: Other

Overview

Bracco Sine Pharmaceutical manufactures and markets contrast agents and diagnostic imaging solutions (X-ray, MRI, ultrasound, nuclear medicine) for healthcare providers in China and Southeast Asia; recent clinical progress includes advanced ultrasound microbubble agents for targeted imaging of tumor vasculature (VEGFR2), showing promising detection in ovarian, breast, and pancreatic cancers in ongoing clinical development

Therapeutic areas: OncologyCardiovascularOther
Modalities: Small moleculeContrast agentRadiopharmaceuticalMicrobubble-based imaging agent
Industry: Medical Imaging

Partnerships

Shanghai Sine Pharmaceutical (JV partner)Shanghai Pharmaceuticals (further strategic partnership)Blue Earth Diagnostics (Bracco Group acquisition)

Beyond the preview

Go deeper on Bracco Sine Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bracco Sine Pharmaceutical.

Explore the full profile